Clinical Trial Update: Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating long-term anticoagulation with an oral Factor Xa inhibitor versus a vitamin K antagonist after mechanical aortic valve replace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Thromboembolism

Drugs mentioned

• Oral Factor Xa inhibitor
• Warfarin (warfarin)

Snippet

Sponsor: Joon Bum Kim | Conditions: AORTIC VALVE DISEASES, Thromboembolism | Phase 4 | Status: RECRUITING